COVID-10 in obstetrics and neonatology: regional experience


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective: Analysis of COVID-19 clinical course based on mild and moderate symptoms of coronavirus infection in infants born to SARS- CoV-2 positive women, and evaluation of their adaptation in postnatal period. Materials and methods: A retrospective analysis of medical records of 280 pregnant women, who had confirmed clinical diagnosis of coronavirus infection with mild and moderate symptoms of COVID-19 and medical records of 267 infants born to women with SARS-CoV-2 infection, who are residents of the North Caucasian Federal District (the Republic of Ingushetia, Dagestan and North Ossetia-Alania). Results: The analysis of the course of the disease and major laboratory test results did not show significant differences between pregnant women with mild and moderate COVID-19 depending on the gestational age at the time of infection. High temperature, continuous cough, a loss or change to the sense of smell and taste, chest pain with breathing were the most common symptoms during three trimesters of pregnancy. Assessment of clinical laboratory results in pregnant women with COVID-10 and in infants born to patients with COVID-19 showed that biochemical blood test and a complete blood count play an important role in assessment of severity and prognosis of the disease. The data on the clinical manifestations of COVID-19 in pregnant women showed that immune responses induced by COVID-19 do not correlate with the severity of the disease. The analysis of infants’ health records showed that 12/267 (4.5%) newborns required admission to NICU due to low oxygen saturation levels, shortness of breath and tachypnea; 7/267 (2.6%) newborns required mechanical ventilation. Conclusion: Most likely, the severity of COVID-19 in pregnant women depends not only and not so much on gestational age, but also on the presence of concomitant extragenital pathology and aggravated obstetric and gynecological anamnesis. Apparently, it is important that approach to management of pregnant women based on obstetric indications and maternal and fetal condition should individualized. Perinatal complications in newborns are likely due to impaired placental perfusion and/or thrombotic changes in mother, decreased barrier function and placental inflammatory changes. The issues discussed in this article confirm the high relevance of the problem of infants’ health status who were born to mother, who underwent COVID-19 at different terms of pregnancy, and this poses new challenges for identification of important features in monitoring, diagnosis, therapy and prevention of pathological conditions in newborns.

Full Text

Restricted Access

About the authors

Asiyat E. Esedova

Dagestan State Medical University

Email: asiyat.idrisova@bk.ru
Dr. Med. Sci., Professor, Head of the Department of Obstetrics and Gynecology of the Pediatric, Dental and Preventive Medicine Faculties

Razin M. Ragimov

Dagestan State Medical University

Email: razinragimov@mail.ru
Dr. Med. Sci., Professor, Head of the Department of Normal Physiology

Zareta M. Gatagazheva

Ingush State University

Email: ing_gu@mail.ru; zaretai@list.ru
Dr. Med. Sci., Associate Professor, Head of the Department of Obstetrics and Gynecology, Faculty of Medicine

Naida M. Abdullaeva

Dagestan State Medical University

PhD (Bio), Associate Professor of the Department of Normal Physiology, Head of the Department of Grants and Innovations

Muminat A. Idrisova

Dagestan State Medical University

Email: muminat.idrisova.88@mail.ru
PhD, Assistant of the Department of Obstetrics and Gynecology of the Pediatric, Dental and Preventive Medicine Faculties

Malika M. Gatagazheva

Ingush State University

Email: ing_gu@mail.ru; amira76@list.ru
PhD, Associate Professor, Head of the Department of Obstetrics and Gynecology, Faculty of Medicine

Zarina A. Daurova

North Ossetian State Medical Academy

Email: daurova.zarina@mail.ru
postgraduate student of the Department of Obstetrics and Gynecology No. 2

References

  1. Yan J., Guo J., Fan C., Juan J., Yu X., Li J. et al. Coronavirus disease 2019 in pregnant women: a report based on 116 cases. Am. J. Obstet. Gynecol. 2020; 223(1): 111.e1-111.e14. https://dx.doi.org/10.1016/j.ajog.2020.04.014.
  2. Liu H., WangLi.L., Zhao Si.J., Kwak-Kim J., Mor G., Liao Ai.H. Why are pregnant women susceptible to COVID-19? An immunological viewpoint. J. Reprod. Immunol. 2020; 139: 103122. https://dx.doi.org/10.1016/j.jri.2020.103122.
  3. Shanes E.D., Mithal L.B., Otero S., Azad H.A., Miller E.S., Goldstein J.A. Pathology in COVID-19. Am. J. Clin. Pathol. 2020; 154(1): 23-32. https://dx.doi.org/10.1093/ajcp/aqaa089.
  4. Elshafeey E., Magdi R., Hindi N., Elshebiny M., Farrag N., Mahdy S. et al. A systematic scoping review of COVID-19 during pregnancy and childbirth. Int. J. Gynaecol. Obstet. 2020; 150(1): 47-52. https://dx.doi.org/10.1093/ajcp/aqaa08910.1002/ijgo.13182.
  5. Martin-Vicente M., Almansa R., Martinez I., Tedim A.P., Bustamante E., Tamayo L. et al. Low anti-SARS-CoV-2 S. antibody levels predict increased mortality and dissemination of viral components in the blood of critical COVID-19 patients. J. Intern. Med. 2022; 291(2): 232-40. https://dx.doi.org/10.1111/joim.13386.
  6. Zhao Y., Zhao Z., Wang Y., Zhou Y., Ma Y., Zuo W. Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov. bioRxiv. 2020; 01: 26.919985. https://dx.doi.org/10.1101/2020.01.26.919985.
  7. Sevajol M., Subissi L., Decroly E., Canard B., Imbert I. Review insights into RNA synthesis, capping, and proofreading mechanisms of SARS-coronavirus. Virus Res. 2014; 194: 90-9. https://dx.doi.org/10.1016/j.virusres.2014.10.008.
  8. Di Mascio D., Khalil A., Saccone G., Rizzo G., Buca D., Lib era ti M. et al. Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis. Am. J. Obstet. Gynecol. MFM. 2020; 2(2): 100107. https://dx.doi.org/10.1016/j.ajogmf.2020.100107.
  9. Schwartz D.A., Graham A.L. Potential maternal and infant outcomes from (Wuhan) coronavirus 2019-nCoV infecting pregnant women: lessons from SARS, MERS, and other human coronavirus infections. Viruses. 2020; 12(2): 194. https://dx.doi.org/10.3390/v12020194.
  10. Baud D., Greub G., Favre G., Gengler C., Jaton K., Dubruc E., Pomar L. Second-trimester miscarriage in a pregnant woman with SARS-CoV-2 infection. JAMA. 2020; 323(21): 2198-200. https://dx.doi.org/10.1001/jama.2020.7233.
  11. Sanchez-Luna M., Colomer B.F., de Alba Romero C., Allen A.A., Souto A.B., Camba Longueira F. et al. Neonates born to mothers with COVID-19: data from the Spanish society of neonatology registry. Pediatrics. 2021: 147(2): e2020015065. https://dx.doi.org/10.1542/peds.2020-015065.
  12. Shanes E.D., Mithal L.B., Otero S., Azad H.A., Miller E.S., Goldstein J.A. Placental pathology in COVID-19. Am. J. Clin. Pathol. 2020; 154(1): 23-32. https://dx.doi.org/10.1093/ajcp/aqaa089.
  13. Simoes E. Silva A.C., Leal C.R.V. Is SARS-CoV-2 vertically transmitted? Front. Pediatr. 2020; 8: 276. https://dx.doi.org/10.3389/fped.2020.00276.
  14. Suy A., Garcia-Ruiz I., Carbonell M., Garcia-Manau P., Rodo C., Maiz N. et al. Gestation and COVID-19: clinical and microbiological observational study (Gesta-COVID19). BMC Pregnancy Childbirth. 2021; 21(1): 78. https://dx.doi.org/10.1186/s12884-021-03572-4.
  15. Verma S., Bradshaw C., Auyeung N.S.F., Lumba R., Farkas J.S., Sweeney N.B. et al. Outcomes of maternal-newborn dyads after maternal SARS-CoV-2. Pediatrics. 2020; 146(4): e2020005637. https://dx.doi.org/10.1542/peds.2020-005637.
  16. Vivanti A.J., Vauloup-Fellous C., Prevot S., Zupan V., Suffee C., Do Cao J. et al. Transplacental transmission of SARS-CoV-2 infection. Nat. Commun. 2020; 11(1): 3572. https://dx.doi.org/10.1038/s41467-020-17436-6.
  17. Chamseddine R.S., Wahbeh F., Chervenak F., Salomon L.J., Ahmed B., Rafii A. Pregnancy and neonatal outcomes in SARS-CoV-2 infection: a systematic review. J. Pregnancy. 2020; 2020: 45924. https://dx.doi.org/10.1155/2020/4592450.
  18. Wiersinga W.J., Rhodes A., Cheng A.C., Peacock S.J., Prescott H.C. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA. 2020; 324(8): 782-93. https://dx.doi.org/10.1001/jama.2020.12839.
  19. Wu Z., McGoogan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020: 323(13): 1239-42. https://dx.doi.org/10.1001/jama.2020.2648.
  20. Абатуров А.Е., Агафонова Е.А., Кривуша Е.Л., Никулина А.А. Патогенез COVID-19. Здоровье ребенка. 2020; 15(2): 133-44.
  21. Белокриницкая Т.Е., Артымук Н.В., Филиппов О.С., Фролова Н.И. Клиническое течение, материнские и перинатальные исходы новой коронавирусной инфекции COVID-19 у беременных Сибири и Дальнего Востока. Акушерство и гинекология. 2021; 2: 48-54. [Belokrinitskaya T.E., Artymuk N.V., Filippov O.S., Frolova N.I. Clinical course, maternal and perinatal outcomes of the new COVID-19 coronavirus infection in pregnant women of Siberia and the Far East. Obstetrics and Gynecology. 2021; 2: 48-54. (in Russian)]. https://dx.doi.org/10.18565/aig.2021.2.48-54.
  22. Коммуникационный центр правительства Российской Федерации. Отчет о текущей ситуации по борьбе с коронавирусом. 01.08.2021.
  23. Щеголев А.И., Туманова У.Н., Серов В.Н. Поражения плаценты у беременных с SARS-CoV-2-инфекцией. Акушерство и гинекология. 2020; 12: 44-52. [Shchegolev A.I., Tumanova U.N., Serov V.N. Placental lesions in pregnant women with SARS-CoV-2 infection. Obstetrics and Gynecology. 2020; 12: 44-52. (in Russian)]. https://dx.doi.org/10.18565/aig.2020.12.44-52.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies